✦ LIBER ✦

M-2 protocol for melphalan-resistant and relapsing multiple myeloma

✍ Scribed by Dr. Michele Cavo; Piero Galieni; Cristina Tassi; Marco Gobbi; Sante Tura

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Melphalan-resistant multiple myeloma: re

✍ B. Steinke; F. W. Busch; C. Becherer; P. Ostendorf; H. D. Waller 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 246 KB

Chemotherapy for resistant and relapsing

✍ Raymond Alexanian; Bart Barlogie; Gerard Ventura 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB

Lenalidomide, melphalan, prednisone and

✍ Larocca, A; Falco, P; Sanpaolo, G; Falcone, A P; Federico, V; Canepa, L; Crugnol 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 307 KB

Bortezomib, low-dose intravenous melphal

✍ Rakesh Popat; Heather Oakervee; Catherine Williams; Mark Cook; Charles Craddock; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Improved survival times in multiple myel

✍ Delvyn C. Case Jr.; Burton J. Lee III; Bayard D. Clarkson 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 753 KB

Intermediate-dose (25 mg/m2) intravenous

✍ M. T. Petrucci; G. Avvisati; Dr. M. Tribalto; M. Cantonetti; P. Giovangrossi; F. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB